Literature DB >> 29353128

Adoption, penetration, and effectiveness of a secondary risk screener for intimate partner violence: Evidence to inform screening practices in integrated care settings.

Katherine M Iverson1, Anneliese E Sorrentino2, Scarlett L Bellamy3, Alessandra R Grillo4, Terri N Haywood2, Elina Medvedeva2, Christopher B Roberts2, Melissa E Dichter5.   

Abstract

OBJECTIVE: Veterans Health Administration (VHA) has implemented screening for past-year intimate partner violence (IPV) in some healthcare facilities along with secondary screening of risk for severe violence among those screening positive in order to facilitate follow-up care for high-risk patients. We evaluated the adoption, penetration, and effectiveness of secondary screening as a tool to facilitate timely follow-up services.
METHODS: Retrospective review of medical records (screening and healthcare use) of 774 women screening positive for past-year IPV (IPV+) at 11 facilities nationwide from April 2014-April 2016. Chi-square and t-tests examined factors related to secondary screening.
RESULTS: Three of eleven (27.3%) facilities that implemented primary IPV screening adopted secondary screening. At adopting sites, 56.4% eligible (i.e., IPV+) women received secondary screening. Among 185 IPV+ women who completed secondary screening, 33.0% screened positive for severe IPV. Screening positive during secondary screening was associated with higher rate of psychosocial care within 60 days (73.8% vs. 54.0% of IPV+ patients screening negative; p < .05), posttraumatic stress disorder diagnosis (31.1% vs. 15.3%; p < .05), and being physically threatened or harmed (>50% vs. <15%; p < .001).
CONCLUSIONS: Secondary risk assessment following IPV screening may expedite access to psychosocial follow-up care in integrated healthcare settings. However, program uptake needs to be enhanced. Published by Elsevier Inc.

Entities:  

Keywords:  Behavioral health; Implementation; Screening; Service utilization; Timeliness; Women veterans

Mesh:

Year:  2018        PMID: 29353128     DOI: 10.1016/j.genhosppsych.2018.01.002

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  5 in total

1.  Intimate Partner Violence Screening Programs in the Veterans Health Administration: Informing Scale-up of Successful Practices.

Authors:  Katherine M Iverson; Omonyêlé Adjognon; Alessandra R Grillo; Melissa E Dichter; Cassidy A Gutner; Alison B Hamilton; Shannon Wiltsey Stirman; Megan R Gerber
Journal:  J Gen Intern Med       Date:  2019-08-16       Impact factor: 5.128

2.  Opportunities to More Comprehensively Assess Sexual Violence Experience in Veterans Health Administration Medical Records Data.

Authors:  Brittany F Hollis; Nadejda Kim; Ada Youk; Melissa E Dichter
Journal:  J Gen Intern Med       Date:  2022-08-30       Impact factor: 6.473

3.  Assessing the Veterans Health Administration's response to intimate partner violence among women: protocol for a randomized hybrid type 2 implementation-effectiveness trial.

Authors:  Katherine M Iverson; Melissa E Dichter; Kelly Stolzmann; Omonyêlé L Adjognon; Robert A Lew; LeAnn E Bruce; Megan R Gerber; Galina A Portnoy; Christopher J Miller
Journal:  Implement Sci       Date:  2020-05-07       Impact factor: 7.327

4.  Assessment of intimate partner violence abuse ratings by recently abused and never abused women.

Authors:  Helen E Straus; Elizabeth H Guonjian; Errick Christian; Rebecca R Roberts
Journal:  BMC Womens Health       Date:  2020-08-17       Impact factor: 2.809

Review 5.  Health Service Interventions for Intimate Partner Violence among Military Personnel and Veterans: A Framework and Scoping Review.

Authors:  Sean Cowlishaw; Alyssa Sbisa; Isabella Freijah; Dzenana Kartal; Ashlee Mulligan; MaryAnn Notarianni; Katherine Iverson; Anne-Laure Couineau; David Forbes; Meaghan O'Donnell; Andrea Phelps; Patrick Smith; Fardous Hosseiny
Journal:  Int J Environ Res Public Health       Date:  2022-03-17       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.